Beranda › Kanker Payudara › Illinois › Waukegan
Uji klinis Kanker Payudara di Waukegan, IL
12 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Waukegan (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- AMG Libertyville - Oncology, Libertyville · 8 mi jauhnya
- Condell Memorial Hospital, Libertyville · 8 mi jauhnya
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Menerima pesertaFase 2
- City of Hope Chicago, Zion · 6 mi jauhnya
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Menerima pesertaFase 1/2
- City of Hope, Chicago, Zion · 6 mi jauhnya
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Menerima pesertaFase 1/2
- City of Hope® Cancer Center Chicago, Zion · 6 mi jauhnya
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Menerima pesertaFase 1
- City of Hope - Chicago, Zion · 6 mi jauhnya
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Menerima pesertaFase 1/2
- City of Hope® Cancer Center Chicago, Zion · 6 mi jauhnya
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Menerima pesertaFase 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi jauhnya
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauhnya
- AMG Libertyville - Oncology, Libertyville · 8 mi jauhnya
- Condell Memorial Hospital, Libertyville · 8 mi jauhnya
- dan 1 lainnya
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Menerima pesertaFase 3
- City of Hope - Cancer Center Chicago, Zion · 6 mi jauhnya
E-Mindfulness Approaches for Living After Breast Cancer
Menerima pesertaFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauhnya
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi jauhnya
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Menerima pesertaFase 3
- Midwestern Regional Medical Center, Zion · 6 mi jauhnya
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauhnya
- AMG Libertyville - Oncology, Libertyville · 8 mi jauhnya
- dan 2 lainnya
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- AMG Libertyville - Oncology, Libertyville · 8 mi jauhnya
- Condell Memorial Hospital, Libertyville · 8 mi jauhnya
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Waukegan
- Kanker Paru Non-Sel Kecil16 studi
- Kanker Paru16 studi
- Kolitis Ulseratif7 studi
- Kanker Ginjal (Karsinoma Sel Renal)7 studi
- Kanker Ovarium6 studi
- Kanker Metastatik6 studi
- Karsinoma Sel Skuamosa Kepala dan Leher6 studi
- Kanker Kolorektal6 studi
- Kanker Prostat6 studi
- Melanoma5 studi
- Leukemia Mieloid Akut5 studi
- Penyakit Crohn5 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.